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Propranolol is a non-selective beta blocker drug that has a high first pass metabolism in
oral route of administration. This phenomenon is so high in this drug that practically
just 25 percent of consumed drug reaches the systemic circulation. Therefore,
considering some previous researches around non-oral propranolol formulations, we
decided to design a mucoadhesive drug delivery system which resolve the first pass
metabolism issue and probably increase systemic effectiveness.
Orabase is an oral mucoadhesive paste prepared by compounding of sodium carboxy
methyl cellulose, pectin and gelatin in plastibase. Plastibase is a paste base prepared by
shock cooling of hot polyethylene in liquid paraffin mixture. Several formulations of
different percent of above ingredients with different methods were prepared and their
organoleptic properties, existence of individual particles, uniformity and thumb test
were studied. Five formulations were found suitable.
These formulations were studied with second control experiments (adherence and
occlusivity). One formulation was accepted.
Drug standard curve was carried out by spectrophotometry method using 96 ethanol
with different concentrations of dexamethasone and l"max was 290 nm.
The results showed that this method has a high accuracy and precision. After that the
mucoadhesive paste was prepared and occlusivity, adherence and rheological properties
was determined. Then the formulation was checked for diffusion studies. Franz
diffusion cell was used for release studies.
The results showed that propranolol can be formulated in mucoadhesive base with
appropriate physicochemical properties.
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